TSO3 Inc. to Post FY2018 Earnings of ($0.13) Per Share, Desjardins Forecasts (TOS)

TSO3 Inc. (TSE:TOS) – Equities researchers at Desjardins decreased their FY2018 EPS estimates for shares of TSO3 in a research report issued to clients and investors on Thursday. Desjardins analyst F. Tremblay now anticipates that the company will post earnings of ($0.13) per share for the year, down from their previous estimate of ($0.07). Desjardins currently has a “Hold” rating and a $1.60 target price on the stock. Desjardins also issued estimates for TSO3’s FY2019 earnings at ($0.05) EPS.

How to Become a New Pot Stock Millionaire

A number of other brokerages also recently weighed in on TOS. National Bank Financial downgraded shares of TSO3 from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from C$5.50 to C$2.25 in a research report on Monday, January 29th. Canaccord Genuity downgraded shares of TSO3 from a “buy” rating to a “speculative buy” rating and lowered their price objective for the company from C$4.25 to C$2.75 in a research report on Friday, January 26th. Royal Bank of Canada downgraded shares of TSO3 from an “outperform” rating to a “sector perform” rating and lowered their price objective for the company from C$4.25 to C$2.00 in a research report on Friday, January 26th. Finally, Scotiabank lowered their price objective on shares of TSO3 from C$4.50 to C$2.75 and set an “outperform” rating on the stock in a research report on Tuesday, January 30th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. TSO3 presently has a consensus rating of “Hold” and a consensus price target of C$2.12.

TSO3 (TSE:TOS) opened at C$1.05 on Monday. The firm has a market cap of $105.96, a P/E ratio of -9.55 and a beta of 1.11. TSO3 has a 52-week low of C$0.94 and a 52-week high of C$3.32.

TRADEMARK VIOLATION NOTICE: “TSO3 Inc. to Post FY2018 Earnings of ($0.13) Per Share, Desjardins Forecasts (TOS)” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3303507/tso3-inc-to-post-fy2018-earnings-of-0-13-per-share-desjardins-forecasts-tos.html.

TSO3 Company Profile

TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.

Earnings History and Estimates for TSO3 (TSE:TOS)

Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

J.Jill  Downgraded by ValuEngine
J.Jill Downgraded by ValuEngine
Neurometrix  Rating Lowered to Hold at ValuEngine
Neurometrix Rating Lowered to Hold at ValuEngine
Bell Canada  Hits New 1-Year High and Low at $42.00
Bell Canada Hits New 1-Year High and Low at $42.00
Building Materials  Hits New 52-Week High and Low at $18.00
Building Materials Hits New 52-Week High and Low at $18.00
LTC Properties  Reaches New 1-Year High and Low at $36.05
LTC Properties Reaches New 1-Year High and Low at $36.05
Analysts Set Sarepta Therapeutics Inc  PT at $80.47
Analysts Set Sarepta Therapeutics Inc PT at $80.47


© 2006-2018 Ticker Report. Google+.